Decline of emergency admissions for cardiovascular and cerebrovascular events after the outbreak of COVID-19
Open Access
- 1 December 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical Research in Cardiology
- Vol. 109 (12), 1500-1506
- https://doi.org/10.1007/s00392-020-01688-9
Abstract
Background The spread of the novel coronavirus SARS-CoV-2 and the guidance from authorities for social distancing and media reporting lead to significant uncertainty in Germany. Concerns have been expressed regarding the underdiagnosing of harmful diseases. We explored the rates of emergency presentations for acute coronary syndrome (ACS) and acute cerebrovascular events (ACVE) before and after spread of SARS-CoV-2. Methods We analyzed all-cause visits at a tertiary university emergency department and admissions for ACS and ACVE before (calendar weeks 1-9, 2020) and after (calendar weeks 10-16, 2020) the first coronavirus disease (COVID-19) case in the region of the Saarland, Germany. The data were compared with the same period of the previous year. Results In 2020 an average of 346 patients per week presented at the emergency department whereas in 2019 an average of 400 patients presented up to calendar week 16 (p = 0.018; whole year 2019 = 395 patients per week). After the first COVID-19 diagnosis in the region, emergency department visit volume decreased by 30% compared with the same period in 2019 (p = 0.0012). Admissions due to ACS decreased by 41% (p = 0.0023 for all; Delta - 71% (p = 0.007) for unstable angina, Delta - 25% (p = 0.42) for myocardial infarction with ST-elevation and Delta - 17% (p = 0.28) without ST-elevation) compared with the same period in 2019 and decreased from 142 patients in calendar weeks 1-9 to 62 patients in calendar weeks 10-16. ACVE decreased numerically by 20% [p = 0.25 for all; transient ischemic attack: Delta - 32% (p = 0.18), ischemic stroke: Delta - 23% (p = 0.48), intracerebral haemorrhage: Delta + 57% (p = 0.4)]. There was no significant change in ACVE per week (p = 0.7) comparing calendar weeks 1-9 (213 patients) and weeks 10-16 (147 patients). Testing of 3756 samples was performed to detect 58 SARS-CoV-2 positive patients (prevalence 1,54%, thereof one patient with myocardial and two with cerebral ischemia) up to calendar week 16 in 2020. Conclusions The COVID-19 pandemic was associated with a significant decrease in all-cause admission and admissions due to cardiovascular events in the emergency department. Regarding acute cerebrovascular events there was a numerical decrease but no significant difference.This publication has 26 references indexed in Scilit:
- The association of conventionally medicated systolic and diastolic blood pressure level and mortality from cardiovascular disease: is the lower the better in high stroke population?Clinical Research in Cardiology, 2020
- Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damageEuropean Heart Journal, 2020
- COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment optionsCardiovascular Research, 2020
- An increasing risk of family violence during the Covid-19 pandemic: Strengthening community collaborations to save livesForensic Science International: Reports, 2020
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19Thrombosis Research, 2020
- Covid-19: A&E visits in England fall by 25% in week after lockdownPublished by BMJ ,2020
- Christmas, national holidays, sport events, and time factors as triggers of acute myocardial infarction: SWEDEHEART observational study 1998-2013BMJ, 2018
- Mortality differences in acute myocardial infarction patients in the Netherlands: The weekend-effectAmerican Heart Journal, 2018
- Therapeutic implications of drug 'holidays'European Heart Journal, 1996
- Hemorrhagic cerebral infarction--a prospective study.Stroke, 1986